Blue Goose Capital

Blue Goose Capital is a venture capital firm founded in 2018 and located in Cambridge, Massachusetts. The firm focuses on investing in the healthcare sector, specifically targeting biopharmaceutical, data, and medical device companies. Blue Goose Capital initiates its investments with seed capital and is currently managing its second fund, which exclusively invests in U.S. biotechnology firms beginning at the Series A stage. The firm aims to support innovative solutions within the healthcare industry.

http://bluegoosecap.com/

https://crunchbase.com/organization/blue-goose-capital

https://linkedin.com/company/blue-goose-capital

https://pitchbook.com/profiles/investor/502623-91

Doug Zingale

Managing Partner

1 past transactions

AtG Therapeutics

Seed Round in 2022

AtG Therapeutics is a spin-off from the Bellvitge Biomedical Research Institute and the Catalan Institute of Oncology in Barcelona, focusing on the discovery and development of innovative therapeutic techniques to combat cancer resistance. The company is dedicated to creating novel classes of drugs and biomarkers aimed at preventing therapeutic resistance in cancer treatment. By advancing new mechanisms and technologies, AtG Therapeutics seeks to enhance the quality of life for patients affected by cancer, addressing a significant challenge in oncology care.

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.